Literature DB >> 23881064

Benefits of small volume and small syringe for bone marrow aspirations of mesenchymal stem cells.

Philippe Hernigou1, Yasuhiro Homma, Charles Henri Flouzat Lachaniette, Alexandre Poignard, Jerome Allain, Nathalie Chevallier, Helene Rouard.   

Abstract

PURPOSE: Aspirating bone marrow from the iliac crest using small volumes of 1-4 ml with a 10-ml syringe has been historically proposed for harvesting adult mesenchymal stem cells and described as a standard technique to avoid blood dilution. The disadvantage of repeated small aspirations is that there is a significantly increased time to harvest the bone marrow. However, it is not known if a large volume syringe can improve the rate of bone marrow aspiration without increasing blood dilution, thus reducing the quality of the aspirate. We compared the concentrations of mesenchymal stem cells obtained under normal conditions with two different size syringes.
METHODS: Thirty adults (16 men and 14 women with a mean age of 49 ± 14 years) underwent surgery with aspiration of bone marrow from their iliac crest. Bilateral aspirates were obtained from the iliac crest of the same patients with a 10-ml syringe and a 50-ml syringe. Cell analysis determined the frequencies of mesenchymal stem cells (as determined by the number of colonies) from each size of syringe. The cell count, progenitor cell concentration (colonies/ml marrow) and progenitor cell frequency (per million nucleated cells) were calculated. All bone marrow aspirates were harvested by the same surgeon.
RESULTS: Aspirates of bone marrow demonstrated greater concentrations of mesenchymal stem cells with a 10-ml syringe compared with matched controls using a 50-ml syringe. Progenitor cell concentrations were on average 300 % higher using a 10-ml syringe than matched controls using a 50-ml syringe (p < 0.01).
CONCLUSIONS: In normal human donors, bone marrow aspiration from 30 patients demonstrated a reduced mesenchymal stem cell number in aspirates obtained using a larger volume syringe (50 ml) as compared with a smaller volume syringe (10 ml).

Entities:  

Mesh:

Year:  2013        PMID: 23881064      PMCID: PMC3824897          DOI: 10.1007/s00264-013-2017-z

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  16 in total

1.  Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis.

Authors:  P Hernigou; F Beaujean; J C Lambotte
Journal:  J Bone Joint Surg Br       Date:  1999-03

Review 2.  Circulating mesenchymal stem cells.

Authors:  C A Roufosse; N C Direkze; W R Otto; N A Wright
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

Review 3.  Stromal stem cells: marrow-derived osteogenic precursors.

Authors:  M Owen; A J Friedenstein
Journal:  Ciba Found Symp       Date:  1988

4.  Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny.

Authors:  H Castro-Malaspina; R E Gay; G Resnick; N Kapoor; P Meyers; D Chiarieri; S McKenzie; H E Broxmeyer; M A Moore
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

5.  Circulating osteoblast-lineage cells in humans.

Authors:  Guiti Z Eghbali-Fatourechi; Jesse Lamsam; Daniel Fraser; David Nagel; B Lawrence Riggs; Sundeep Khosla
Journal:  N Engl J Med       Date:  2005-05-12       Impact factor: 91.245

6.  Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume.

Authors:  G F Muschler; C Boehm; K Easley
Journal:  J Bone Joint Surg Am       Date:  1997-11       Impact factor: 5.284

7.  Compressed homologous cancellous bone and bone morphogenetic protein (BMP)-7 or bone marrow accelerate healing of long-bone critical defects.

Authors:  T Djapic; V Kusec; M Jelic; S Vukicevic; M Pecina
Journal:  Int Orthop       Date:  2003-08-26       Impact factor: 3.075

8.  Circulating connective tissue precursors: extreme rarity in humans and chondrogenic potential in guinea pigs.

Authors:  Sergei A Kuznetsov; Mahesh H Mankani; Arabella I Leet; Navid Ziran; Stan Gronthos; Pamela Gehron Robey
Journal:  Stem Cells       Date:  2007-04-26       Impact factor: 6.277

9.  Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis.

Authors:  Hsuan-Shu Lee; Guan-Tarn Huang; Hongsen Chiang; Ling-Ling Chiou; Min-Huey Chen; Chang-Hsun Hsieh; Ching-Chuan Jiang
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

10.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

View more
  60 in total

1.  Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up.

Authors:  Kenneth Pettine; Richard Suzuki; Theodore Sand; Matthew Murphy
Journal:  Int Orthop       Date:  2015-07-10       Impact factor: 3.075

Review 2.  History of concentrated or expanded mesenchymal stem cells for hip osteonecrosis: is there a target number for osteonecrosis repair?

Authors:  Philippe Hernigou; Gilles Guerin; Yasuhiro Homma; Arnaud Dubory; Nathalie Chevallier; Hélène Rouard; Charles Henri Flouzat Lachaniette
Journal:  Int Orthop       Date:  2018-05-24       Impact factor: 3.075

Review 3.  Ultrasound imaging and guidance in the management of knee osteoarthritis in regenerative medicine field.

Authors:  Alper Murat Ulasli; Levent Ozcakar; William D Murrel
Journal:  J Clin Orthop Trauma       Date:  2018-11-30

4.  Local transplantation of bone marrow concentrated granulocytes precursors can cure without antibiotics infected nonunion of polytraumatic patients in absence of bone defect.

Authors:  Philippe Hernigou; Matthieu Trousselier; François Roubineau; Charlie Bouthors; Nathalie Chevallier; Helene Rouard; Charles Henri Flouzat-Lachaniette
Journal:  Int Orthop       Date:  2016-03-01       Impact factor: 3.075

5.  Supercharging irradiated allografts with mesenchymal stem cells improves acetabular bone grafting in revision arthroplasty.

Authors:  Philippe Hernigou; Jacques Pariat; Steffen Queinnec; Yasuhiro Homma; Charles Henri Flouzat Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2014-02-09       Impact factor: 3.075

Review 6.  Mesenchymal Stem Cells in the Musculoskeletal System: From Animal Models to Human Tissue Regeneration?

Authors:  Klemen Čamernik; Ariana Barlič; Matej Drobnič; Janja Marc; Matjaž Jeras; Janja Zupan
Journal:  Stem Cell Rev Rep       Date:  2018-06       Impact factor: 5.739

7.  Multipotential stromal cell abundance in cellular bone allograft: comparison with fresh age-matched iliac crest bone and bone marrow aspirate.

Authors:  Thomas G Baboolal; Sally A Boxall; Yasser M El-Sherbiny; Timothy A Moseley; Richard J Cuthbert; Peter V Giannoudis; Dennis McGonagle; Elena Jones
Journal:  Regen Med       Date:  2014-03-12       Impact factor: 3.806

8.  Single-stage treatment of infected tibial non-unions and osteomyelitis with bone marrow granulocytes precursors protecting bone graft.

Authors:  Philippe Hernigou; Arnaud Dubory; Yasuhiro Homma; Charles Henri Flouzat Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2017-11-13       Impact factor: 3.075

9.  Supercharging allografts with mesenchymal stem cells in the operating room during hip revision.

Authors:  Yasuhiro Homma; Kazuo Kaneko; Philippe Hernigou
Journal:  Int Orthop       Date:  2013-12-10       Impact factor: 3.075

Review 10.  The history of bone marrow in orthopaedic surgery (part I trauma): trepanning, bone marrow injection in damage control resuscitation, and bone marrow aspiration to heal fractures.

Authors:  Philippe Hernigou
Journal:  Int Orthop       Date:  2020-02-15       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.